NYBC Ventures is a life sciences investment fund launched by New York Blood Center Enterprises to back early- to mid-stage innovations in blood and cellular therapies and related technologies. The fund leverages NYBCe’s expertise in hematology, transfusion medicine, and cell therapy development to accelerate breakthroughs with patient impact. Based in Boston, Massachusetts, NYBC Ventures focuses on therapeutics, devices, and enabling technologies that address unmet needs in blood-related fields and regenerative medicine. The team includes experienced investors and industry leaders who guide a)
No recent news for this company.